scispace - formally typeset
S

Stephen S. Raab

Researcher at Memorial University of Newfoundland

Publications -  80
Citations -  6021

Stephen S. Raab is an academic researcher from Memorial University of Newfoundland. The author has contributed to research in topics: Fine-needle aspiration & Cytopathology. The author has an hindex of 31, co-authored 79 publications receiving 5791 citations. Previous affiliations of Stephen S. Raab include University of Iowa & Henry Ford Health System.

Papers
More filters
Journal ArticleDOI

Expression of cytokeratin by malignant meningiomas: diagnostic pitfall of cytokeratin to separate malignant meningiomas from metastatic carcinoma.

TL;DR: The results indicated that cytokeratin is not a reliable immunohistochemical marker to separate a malignant meningioma from metastatic carcinoma, and a panel of epithelial markers including Ber-EP4, CEA, B72.3 and CD-15, and vimentin may be needed to separate malignantMeningiomas from metastatics carcinoma.
Journal Article

Telepathologic review: utility, diagnostic accuracy, and interobserver variability on a difficult case consultation service.

TL;DR: It is concluded that, on a difficult case consultation service, pathologists perform significantly better with use of light microscopic than withtelepathologic analysis; rarely make an incorrect diagnosis and do not request that case for light microscopic review; and exhibit high telepathologic diagnostic accuracy in areas of expertise.
Journal Article

Fine needle aspiration biopsy of proliferative breast disease.

TL;DR: Criteria for PBD was employed after 1991, improving on the results from 1991-1992, and there were 53 diagnoses of PBD with or without atypia and 34 were excised.
Journal Article

Diagnostic accuracy and key cytologic features of high-grade transitional cell carcinoma in the upper urinary tract.

TL;DR: Regression analysis showed that the cytologic features of aniso-nucleosis, high nuclear/cytoplasmic ratio, and nuclear overlapping were important in the separation of high-grade TCC from benign lesions.